| Integrative genomics identifies the molecular basis of resistance to azacitidine therapy in myelodysplastic syndromes A Unnikrishnan, E Papaemmanuil, D Beck, NP Deshpande, A Verma, ... Cell reports 20 (3), 572-585, 2017 | 125 | 2017 |
| A novel triple therapy for ITP using high-dose dexamethasone, low-dose rituximab, and cyclosporine (TT4) PYI Choi, F Roncolato, X Badoux, S Ramanathan, SJ Ho, BH Chong Blood, The Journal of the American Society of Hematology 126 (4), 500-503, 2015 | 87 | 2015 |
| A phase 1b study evaluating the safety and efficacy of venetoclax as monotherapy or in combination with azacitidine for the treatment of relapsed/refractory myelodysplastic … AM Zeidan, DA Pollyea, JS Garcia, A Brunner, F Roncolato, U Borate, ... Blood 134, 565, 2019 | 64 | 2019 |
| A phase 1b study of venetoclax and azacitidine combination in patients with relapsed or refractory myelodysplastic syndromes AM Zeidan, U Borate, DA Pollyea, AM Brunner, F Roncolato, JS Garcia, ... American journal of hematology 98 (2), 272-281, 2023 | 40 | 2023 |
| Pathobiology of anaplastic large cell lymphoma PP Piccaluga, A Gazzola, C Mannu, C Agostinelli, F Bacci, E Sabattini, ... Advances in hematology 2010 (1), 345053, 2010 | 35 | 2010 |
| Hemophagocytic lymphohistiocytosis following ChAdOx1 nCov‐19 vaccination S Ai, A Awford, F Roncolato Journal of Medical Virology 94 (1), 14, 2022 | 19 | 2022 |
| Venetoclax and azacitidine in the treatment of patients with relapsed/refractory myelodysplastic syndrome AM Zeidan, U Borate, DA Pollyea, AM Brunner, F Roncolato, JS Garcia, ... Blood 138, 537, 2021 | 18 | 2021 |
| Use of IGK gene rearrangement analysis for clonality assessment of lymphoid malignancies: a single center experience C Mannu, A Gazzola, F Bacci, E Sabattini, C Sagramoso, F Roncolato, ... American Journal of Blood Research 1 (2), 167, 2011 | 17 | 2011 |
| Dose‐adjusted arsenic trioxide for acute promyelocytic leukaemia in chronic renal failure F Firkin, F Roncolato, WK Ho European journal of haematology 95 (4), 331-335, 2015 | 14 | 2015 |
| Targeted molecular therapy in peripheral T-cell lymphomas F Roncolato, A Gazzola, PL Zinzani, SA Pileri, PP Piccaluga, ... Expert Review of Hematology 4 (5), 551-562, 2011 | 14 | 2011 |
| Golidocitinib, a selective JAK1 tyrosine-kinase inhibitor, in patients with refractory or relapsed peripheral T-cell lymphoma (JACKPOT8 Part B): a single-arm, multinational … Y Song, L Malpica, Q Cai, W Zhao, K Zhou, J Wu, H Zhang, N Mehta-Shah, ... The Lancet Oncology 25 (1), 117-125, 2024 | 10 | 2024 |
| Avelumab in combination regimens for Relapsed/Refractory DLBCL: Results from the phase ib JAVELIN DLBCL study EA Hawkes, T Phillips, LE Budde, A Santoro, NS Saba, F Roncolato, ... Targeted oncology 16, 761-771, 2021 | 8 | 2021 |
| An update on safety and preliminary efficacy of highly specific Bruton tyrosine kinase (BTK) inhibitor zanubrutinib in combination with PD-1 inhibitor tislelizumab in patients … CS Tam, G Cull, S Opat, GP Gregory, A Liu, AM Johnston, W Zhao, ... Blood 134, 1594, 2019 | 8 | 2019 |
| Novel fibrinogen (Bβ401Gly→ Val) presents as dys-or hypodysfibrinogenaemia due to alterations in sialic acid content SO Brennan, F Roncolato Thrombosis and haemostasis 106 (09), 551-553, 2011 | 8 | 2011 |
| Associations between smoking and alcohol and follicular lymphoma incidence and survival: a family-based case-control study in Australia MK Odutola, MT van Leeuwen, J Turner, F Bruinsma, JF Seymour, ... Cancers 14 (11), 2710, 2022 | 7 | 2022 |
| Immunomodulatory second-line therapies for immune thrombocytopenia MP Lambert Hämostaseologie 39 (03), 266-271, 2019 | 6 | 2019 |
| Recurrent ventricular fibrillation with different tyrosine kinase inhibitors for chronic myeloid leukemia A Prashar, R Ilsar, F Roncolato, A Hopkins HeartRhythm Case Reports 6 (10), 770-773, 2020 | 4 | 2020 |
| Associations between early-life growth pattern and body size and follicular lymphoma risk and survival: a family-based case-control study MK Odutola, MT van Leeuwen, J Turner, F Bruinsma, JF Seymour, ... Cancer epidemiology 80, 102241, 2022 | 3 | 2022 |
| The mortality of vancomycin-resistant Enterococci Bloodstream Infections (VRE BSI) PYI Choi, B Straube, C Cook, C Van Der Weyden, S Ramanathan, ... Blood 118 (21), 4928, 2011 | 3 | 2011 |
| Occupational exposure to extremely low-frequency magnetic fields and follicular lymphoma risk: a family case–control study MK Odutola, MT van Leeuwen, FJ Bruinsma, G Benke, MC Turner, ... Occupational and environmental medicine 80 (10), 599-602, 2023 | 2 | 2023 |
